https://www.selleckchem.com/products/tas-102.html
No case reported an outcome of death. The median systolic BP increase was 39 (interquartile range (IQR) 32, 59) mmHg and median diastolic BP increase was 28 (IQR 18, 41) mmHg. A total of 27/61 (44%) cases reported treatment for elevated BP (i.e., pharmacologic intervention or emergency department visit/hospitalization). Elevated BP occurred most frequently (28/61, 46%) within a week of the first dose of erenumab. Nineteen cases (19/61, 31%) reported a history of preexisting hypertension. This case series suggest an association between e
Like
Comment
Share
